GLP-1 receptor agonist use, NSW, 2025: Preliminary results from the NSW Population Health Survey

What Market Radar took from it

The figures Market Radar reads from this report, as its data records them, each with the publisher, the place and the date.

1. About 8% of NSW (Australia) adults reported using GLP-1 drugs in 2025; 54% of users take them mainly for weight loss

   NSW Ministry of HealthAustraliaJun 2026n=8,457

Used in Market Radar

The Market Radar pages that use this report.

About this report

Publisher

NSW Ministry of Health

Published

Jun 2026

Type

Official statistics

Sample

n=8,457

Countries

• Australia

Regions

• APAC

Related reports

• What Happens When Shoppers No Longer Do the Shopping?

  EY · 2 Oct 2026 · Survey

• AI shopping agents could reshape competition for Australia's grocery dollar (EY survey of 1,000 Australian adults, June 2026)

  EY · 23 Sep 2026 · Survey

• Circana Australia private label analysis

  Circana · 4 Sep 2026 · Survey

• Rising GLP-1 use could reshape how millions of Australians eat, shop and spend

  EY · 15 Jul 2026 · Survey

• 2025 Consumer Insights Tracker: Food labelling

  Food Standards Australia New Zealand · Mar 2026 · Official statistics

• How many Australians use AI (2026)

  Compare the Market · 21 Jan 2026 · Survey